128 related articles for article (PubMed ID: 17491046)
1. Chronic myelogenous leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.
; Simonsson B
Ann Oncol; 2007 Apr; 18 Suppl 2():ii51-2. PubMed ID: 17491046
[No Abstract] [Full Text] [Related]
2. ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of chronic myelogenous leukemia (CML).
Simonsson B; Kloke O; Stahel RA;
Ann Oncol; 2005; 16 Suppl 1():i52-3. PubMed ID: 15888754
[No Abstract] [Full Text] [Related]
3. Two siblings with chronic myelogenous leukemia.
Kapsali E; Tsiara S; Christou L; Panteli A; Bourantas KL
J Exp Clin Cancer Res; 2000 Dec; 19(4):541-3. PubMed ID: 11277336
[TBL] [Abstract][Full Text] [Related]
4. Long duration priapism in blast crisis of chronic myeloid leukemia.
Dogra PN; Kumar P; Goel R; Dash SC
J Assoc Physicians India; 2004 Feb; 52():170. PubMed ID: 15656063
[No Abstract] [Full Text] [Related]
5. Chronic myelogenous leukemia: ESMO clinical recommendations for the diagnosis, treatment and follow-up.
Hochhaus A; Dreyling M;
Ann Oncol; 2008 May; 19 Suppl 2():ii63-4. PubMed ID: 18456772
[No Abstract] [Full Text] [Related]
6. Marked discordance between cytogenetic/molecular and morphologic findings in a patient with chronic myeloid leukemia.
Rashidi A; Courville E
Blood Cells Mol Dis; 2017 Mar; 63():32-33. PubMed ID: 28110131
[No Abstract] [Full Text] [Related]
7. Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia.
Maiti A; Cortes J; Ferrajoli A; Estrov Z; Borthakur G; Garcia-Manero G; Jabbour E; Ravandi F; O'Brien S; Kantarjian H
Leuk Lymphoma; 2017 Sep; 58(9):1-6. PubMed ID: 28278723
[No Abstract] [Full Text] [Related]
8. Prominent hematogone hyperplasia in BCR-ABL1-positive chronic myelogenous leukemia: mimicking recurrent B-lymphoid blast crisis.
Horna P; Pantazopoulos P; Lancet JE; Moscinski LC; Zhang L
Leuk Lymphoma; 2014 Aug; 55(8):1952-4. PubMed ID: 24304373
[No Abstract] [Full Text] [Related]
9. Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge.
Nand S; Barton K
Leuk Lymphoma; 2007 Feb; 48(2):215-6. PubMed ID: 17325875
[No Abstract] [Full Text] [Related]
10. Juvenile chronic myelogenous leukemia.
Freedman MH; Estrov Z; Chan HS
Am J Pediatr Hematol Oncol; 1988; 10(3):261-7. PubMed ID: 3052147
[TBL] [Abstract][Full Text] [Related]
11. Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Baccarani M; Dreyling M;
Ann Oncol; 2010 May; 21 Suppl 5():v165-7. PubMed ID: 20555071
[No Abstract] [Full Text] [Related]
12. [Chronic myelocytic leukemia in children].
Poliakov VE
Feldsher Akush; 1991 Nov; 56(11):23-9. PubMed ID: 1807975
[No Abstract] [Full Text] [Related]
13. Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy.
Ali MA
Mol Diagn Ther; 2016 Aug; 20(4):315-33. PubMed ID: 27220498
[TBL] [Abstract][Full Text] [Related]
14. [An atypical form of chronic myeloleukemia].
Shapiro AE; Donskaia SB; Drozdova VD; Kireeva SS
Vrach Delo; 1989 Aug; (8):30-1. PubMed ID: 2588520
[No Abstract] [Full Text] [Related]
15. Tyrosine Kinase Inhibitor Treatment for Newly Diagnosed Chronic Myeloid Leukemia.
Radich JP; Mauro MJ
Hematol Oncol Clin North Am; 2017 Aug; 31(4):577-587. PubMed ID: 28673389
[TBL] [Abstract][Full Text] [Related]
16. First case in Tunisia of PH1 positive chronic myelogenous leukemia in a 3 year old child.
Toumi NH; Ben Abid H; Meddeb B; Ben Othman T; Trabelsi C; Boukef K; Hafsia A
Nouv Rev Fr Hematol (1978); 1991; 33(3):275-6. PubMed ID: 1956767
[TBL] [Abstract][Full Text] [Related]
17. [Chronic leukemia].
Shibata A; Narita M
Gan To Kagaku Ryoho; 1989 May; 16(5):1982-8. PubMed ID: 2658837
[TBL] [Abstract][Full Text] [Related]
18. A case report of chronic myelogenous leukemia in a patient with multiple myeloma and a review of the literature.
Ragupathi L; Najfeld V; Chari A; Petersen B; Jagannath S; Mascarenhas J
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):175-9. PubMed ID: 23168212
[No Abstract] [Full Text] [Related]
19. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.
Nishida H; Yoshimizu N; Ueno H; Fujita A; Kato T; Park JW; Yano T; Tobinai K; Ikeda Y
Leuk Res; 2007 Mar; 31(3):417-8. PubMed ID: 16730062
[No Abstract] [Full Text] [Related]
20. Chronic myelogenous leukemia manifested as bilateral proliferative retinopathy.
Mandava N; Costakos D; Bartlett HM
Arch Ophthalmol; 2005 Apr; 123(4):576-7. PubMed ID: 15824241
[No Abstract] [Full Text] [Related]
[Next] [New Search]
